Jeličić, I.; Vukojević, K.; Racetin, A.; Čarić, D.; Glavina Durdov, M.; Saraga-Babić, M.; Filipović, N.
Expression of Pannexin 1 in the Human Kidney during Embryonal, Early Fetal and Postnatal Development and Its Prognostic Significance in Diabetic Nephropathy. Biomedicines 2022, 10, 944.
https://doi.org/10.3390/biomedicines10050944
AMA Style
Jeličić I, Vukojević K, Racetin A, Čarić D, Glavina Durdov M, Saraga-Babić M, Filipović N.
Expression of Pannexin 1 in the Human Kidney during Embryonal, Early Fetal and Postnatal Development and Its Prognostic Significance in Diabetic Nephropathy. Biomedicines. 2022; 10(5):944.
https://doi.org/10.3390/biomedicines10050944
Chicago/Turabian Style
Jeličić, Ivo, Katarina Vukojević, Anita Racetin, Davor Čarić, Merica Glavina Durdov, Mirna Saraga-Babić, and Natalija Filipović.
2022. "Expression of Pannexin 1 in the Human Kidney during Embryonal, Early Fetal and Postnatal Development and Its Prognostic Significance in Diabetic Nephropathy" Biomedicines 10, no. 5: 944.
https://doi.org/10.3390/biomedicines10050944
APA Style
Jeličić, I., Vukojević, K., Racetin, A., Čarić, D., Glavina Durdov, M., Saraga-Babić, M., & Filipović, N.
(2022). Expression of Pannexin 1 in the Human Kidney during Embryonal, Early Fetal and Postnatal Development and Its Prognostic Significance in Diabetic Nephropathy. Biomedicines, 10(5), 944.
https://doi.org/10.3390/biomedicines10050944
